160 related articles for article (PubMed ID: 28825403)
1. Sniffing out the hypoxia volatile metabolic signature of Aspergillus fumigatus.
Rees CA; Stefanuto PH; Beattie SR; Bultman KM; Cramer RA; Hill JE
J Breath Res; 2017 Aug; 11(3):036003. PubMed ID: 28825403
[TBL] [Abstract][Full Text] [Related]
2. Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus.
Chambers ST; Bhandari S; Scott-Thomas A; Syhre M
Med Mycol; 2011 Apr; 49 Suppl 1():S54-61. PubMed ID: 20795766
[TBL] [Abstract][Full Text] [Related]
3. The volatome of Aspergillus fumigatus.
Heddergott C; Calvo AM; Latgé JP
Eukaryot Cell; 2014 Aug; 13(8):1014-25. PubMed ID: 24906414
[TBL] [Abstract][Full Text] [Related]
4. Detection of characteristic metabolites of Aspergillus fumigatus and Candida species using ion mobility spectrometry-metabolic profiling by volatile organic compounds.
Perl T; Jünger M; Vautz W; Nolte J; Kuhns M; Borg-von Zepelin M; Quintel M
Mycoses; 2011 Nov; 54(6):e828-37. PubMed ID: 21668516
[TBL] [Abstract][Full Text] [Related]
5. Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples.
Syhre M; Scotter JM; Chambers ST
Med Mycol; 2008 May; 46(3):209-15. PubMed ID: 18404548
[TBL] [Abstract][Full Text] [Related]
6. Analysis of volatile fingerprints for monitoring anti-fungal efficacy against the primary and opportunistic pathogen Aspergillus fumigatus.
Pont NP; Kendall CA; Magan N
Mycopathologia; 2012 Mar; 173(2-3):93-101. PubMed ID: 21997859
[TBL] [Abstract][Full Text] [Related]
7. A breath fungal secondary metabolite signature to diagnose invasive aspergillosis.
Koo S; Thomas HR; Daniels SD; Lynch RC; Fortier SM; Shea MM; Rearden P; Comolli JC; Baden LR; Marty FM
Clin Infect Dis; 2014 Dec; 59(12):1733-40. PubMed ID: 25342502
[TBL] [Abstract][Full Text] [Related]
8. Breath metabolome of mice infected with Pseudomonas aeruginosa.
Purcaro G; Nasir M; Franchina FA; Rees CA; Aliyeva M; Daphtary N; Wargo MJ; Lundblad LKA; Hill JE
Metabolomics; 2019 Jan; 15(1):10. PubMed ID: 30830447
[TBL] [Abstract][Full Text] [Related]
9. Profiling of volatile organic compounds produced by clinical Aspergillus isolates using gas chromatography-mass spectrometry.
Gerritsen MG; Brinkman P; Escobar N; Bos LD; de Heer K; Meijer M; Janssen HG; de Cock H; Wösten HAB; Visser CE; van Oers MHJ; Sterk PJ
Med Mycol; 2018 Feb; 56(2):253-256. PubMed ID: 28525576
[TBL] [Abstract][Full Text] [Related]
10. Development of an adaptable headspace sampling method for metabolic profiling of the fungal volatome.
Ahmed WM; Geranios P; White IR; Lawal O; Nijsen TM; Bromley MJ; Goodacre R; Read ND; Fowler SJ
Analyst; 2018 Aug; 143(17):4155-4162. PubMed ID: 30069568
[TBL] [Abstract][Full Text] [Related]
11. Evolution of potent odorants within the volatile metabolome of high-quality hazelnuts (Corylus avellana L.): evaluation by comprehensive two-dimensional gas chromatography coupled with mass spectrometry.
Rosso MC; Liberto E; Spigolon N; Fontana M; Somenzi M; Bicchi C; Cordero C
Anal Bioanal Chem; 2018 Jun; 410(15):3491-3506. PubMed ID: 29313080
[TBL] [Abstract][Full Text] [Related]
12. Identification of Pseudomonas aeruginosa and Aspergillus fumigatus mono- and co-cultures based on volatile biomarker combinations.
Neerincx AH; Geurts BP; Habets MFJ; Booij JA; van Loon J; Jansen JJ; Buydens LMC; van Ingen J; Mouton JW; Harren FJM; Wevers RA; Merkus PJFM; Cristescu SM; Kluijtmans LAJ
J Breath Res; 2016 Jan; 10(1):016002. PubMed ID: 26824272
[TBL] [Abstract][Full Text] [Related]
13. Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis.
de Heer K; Kok MG; Fens N; Weersink EJ; Zwinderman AH; van der Schee MP; Visser CE; van Oers MH; Sterk PJ
J Clin Microbiol; 2016 Mar; 54(3):569-75. PubMed ID: 26677251
[TBL] [Abstract][Full Text] [Related]
14. The volatile metabolome of Klebsiella pneumoniae in human blood.
Rees CA; Smolinska A; Hill JE
J Breath Res; 2016 May; 10(2):027101. PubMed ID: 27163334
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the Clostridium difficile volatile metabolome using comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.
Rees CA; Shen A; Hill JE
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1039():8-16. PubMed ID: 27855313
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive volatile metabolic fingerprinting of bacterial and fungal pathogen groups.
Rees CA; Burklund A; Stefanuto PH; Schwartzman JD; Hill JE
J Breath Res; 2018 Jan; 12(2):026001. PubMed ID: 28952968
[TBL] [Abstract][Full Text] [Related]
17. Analysis of extracellular metabolome by HS-SPME/GC-MS: Optimization and application in a pilot study to evaluate galactosamine-induced hepatotoxicity.
Araújo AM; Moreira N; Lima AR; Bastos ML; Carvalho F; Carvalho M; Guedes de Pinho P
Toxicol Lett; 2018 Oct; 295():22-31. PubMed ID: 29852275
[TBL] [Abstract][Full Text] [Related]
18. Expanding the Klebsiella pneumoniae volatile metabolome using advanced analytical instrumentation for the detection of novel metabolites.
Rees CA; Franchina FA; Nordick KV; Kim PJ; Hill JE
J Appl Microbiol; 2017 Mar; 122(3):785-795. PubMed ID: 27930839
[TBL] [Abstract][Full Text] [Related]
19. Microbial volatile communication in human organotypic lung models.
Barkal LJ; Procknow CL; Álvarez-García YR; Niu M; Jiménez-Torres JA; Brockman-Schneider RA; Gern JE; Denlinger LC; Theberge AB; Keller NP; Berthier E; Beebe DJ
Nat Commun; 2017 Nov; 8(1):1770. PubMed ID: 29176665
[TBL] [Abstract][Full Text] [Related]
20. Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus.
Chambers ST; Syhre M; Murdoch DR; McCartin F; Epton MJ
Med Mycol; 2009; 47(5):468-76. PubMed ID: 19301177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
